Pediatrics Doctors in Essex Jct, VT Accepting Medicare
6 Pediatrics doctors found. Showing 1 - 6
 Dr. Paul Mclane Costello, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 89 Main St, Essex Jct, VT 05452 Phone: 802-879-6556 Fax: 802-872-8021 |
Dr. David E Stifler, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 89 Main St, Essex Jct, VT 05452 Phone: 802-879-6556 Fax: 802-872-8021 |
 Dr. Elizabeth H Jillson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 89 Main St, Essex Jct, VT 05452 Phone: 802-879-6556 Fax: 802-872-8021 |
Dr. Jerry Steven Hale, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 89 Main St, Essex Jct, VT 05452 Phone: 802-879-6556 Fax: 802-872-8021 |
Dr. Sandra E Kapsalis, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 89 Main St, Essex Jct, VT 05452 Phone: 802-879-6556 Fax: 802-872-8021 |
Meredith Davies Monahan, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 89 Main St, Essex Jct, VT 05452 Phone: 802-879-6556 Fax: 802-872-8021 |
News Archive
Promedior raises $12M in Series C financing
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat inflammatory and fibrotic diseases, today announced that it has raised $12 million in a Series C financing round. Forbion Capital Partners led the round, with participation from existing investors Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, and Easton Capital. The Series C financing brings the total capital raised by Promedior over the past year to $27 million.
Obstetric fistula: Guiding principles for clinical management and programme development
The World Health Organization (WHO) Goodwill Ambassador for Maternal, Newborn and Child Health and supermodel Liya Kebede has highlighted the plight of millions of women and girls living with obstetric fistula.
Inadequate management common in young-onset Type 2 diabetes
Patients with young-onset Type 2 diabetes have worse metabolic control than those with late-onset disease, but they are less likely to receive organ-protective drugs, show data from the Joint Asia Diabetes Evaluation cohort.
Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix
In the UK there are currently over 3.5 million people who have diabetes, with a growth rate exceeding 280,000 people per year. Diabetic retinopathy is the most common complication of diabetes.
AB SCIEX, Prosolia enter technology license agreement
Prosolia, Inc. and AB SCIEX announced today that they have entered into a license agreement for technologies developed by Dr. Gary Van Berkel and his colleagues of Oak Ridge National Laboratory.
› Verified 8 days ago